Beta-blockers curb death risk in high-risk STEMI patients

02/17/2013 | PhysiciansBriefing.com

A study in The American Journal of Cardiology found beta-blocker treatment may help cut long-term mortality in high-risk ST-segment elevation myocardial infarction patients. However, the therapy did not appear to benefit lower-risk patients, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR